News and Trends 19 Oct 2017
Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia
uniQure is getting ready to start a Phase III clinical trial in 2018 with a new version of its gene therapy for hemophilia B. uniQure has officially launched a plan to bring the first gene therapy for hemophilia to the market. After multiple meetings with the FDA and the EMA, the Dutch biotech has received permission […]